NCT02120066

Completed

Submacular Hemorrhage Associated With Retinal Arterial Macro...

Kyorin University Source

Compare

Other study identifiers

Sponsor study identifier

Kyorineye015

Study Type

interventional

Actual enrollment (reported)

22

Locations

1 country

Sites

1

Timeline

Study Start

January 2011

Date type not reported

This date has not been verified as actual or estimated.

Primary Completion

June 2013

Actual (reported)

Study Completion

April 2014

Actual (reported)

Brief Summary

Evaluation of surgical outcome of vitrectomy with subretinal injection of recombinant tissue-plasminogen activator for submacular hemorrhage associated with retinal arterial macroanuerysms.

Registry Overview

Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.

Recruitment status: completed
Actual enrollment (reported): 22 participants
Study completion date: April 2014
Actual (reported)
Listed locations: 1 countries · 1 sites

Trial Relationships

Click on a node to explore related trials.

Some registry-reported names shown below are not yet linked in this graph.

Study Timeline

Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.

Study Start
January 2011
Date type not reported
This date has not been verified as actual or estimated.
Primary Completion
June 2013
Actual (reported)
Study Completion
April 2014
Actual (reported)
First Submitted
April 15, 2014
Actual (reported)
First Posted
April 22, 2014
Actual (reported)

Last Updated: April 22, 2014
Status Verified: April 2014
Last Update Submitted: April 18, 2014

Conditions

Ruptured Retinal Arterial Macro Aneurysms Submacular Hemorrhage

Keywords

Submacular hemorrhageVitrectomytissue- plasminogen activator

Outcome Measures

Primary Outcomes (1)

Displacement of sub macular hemorrhage
Anatomical recovery detected funduscopy and optical coherence tomography
one year

Secondary Outcomes (1)

Visual acuity
one year

Study Arms (1)

Vitrectomy

OTHER

Procedure: Vitrectomy for submacular hemorrhageDrug: subretinal injection of tissue-plasminogen activator

Interventions

Vitrectomy for submacular hemorrhageProcedure

Vitrectomy

subretinal injection of tissue-plasminogen activatorDrug

Vitrectomy

Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.

Eligibility Criteria

Age40 Years - 95 Years

Sexall

Healthy VolunteersNo

Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

The patients with sub macular hemorrhage associated with ruptured retinal arterial macro aneurysms

You may not qualify if:

Sponsors & Collaborators

Kyorin University
Otherlead

Study Sites (1)

Kyorin Eye Center

Mitaka, Tokyo, 181-8611, Japan

MeSH Terms

Interventions

Vitrectomy

Intervention Hierarchy (Ancestors)

Ophthalmologic Surgical ProceduresSurgical Procedures, Operative

Enrollment

22 participants (actual enrollment reported by the registry).

Study Design

Study Type: interventional
Phase: not applicable
Allocation: NA
Masking: NONE
Purpose: TREATMENT
Intervention Model: SINGLE GROUP
Sponsor Type: OTHER
Responsible Party: PRINCIPAL INVESTIGATOR
PI Title: Associate professor of Ophthalmology

Study Record Dates

First Submitted

April 15, 2014

First Posted

April 22, 2014

Study Start

January 2011

Date type not reported

This date has not been verified as actual or estimated.

The eyes with preretinal or intraretinal hemorrhage at the fovea

The patients with follow-up less than 3 months

Contact the study team to confirm eligibility.

Primary Completion

June 2013

Actual (reported)

Study Completion

April 2014

Actual (reported)

Last Updated

April 22, 2014

Record last verified: 2014-04

Source record

Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.

Source: ClinicalTrials.gov.

JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.

Registry identifier: NCT02120066
Data provider: ClinicalTrials.gov
Source updated: 2014-04-22
Normalization version: ctgov-legacy-1

Open registry record

Source retrieved: 2026-10-25 22:35:02 UTC

Locations

JP(1)

Submacular Hemorrhage Associated With Retinal Arterial Macro Aneurysm

Brief Summary

Registry Overview

Trial Relationships

Study Timeline

Study Start

Primary Completion

Study Completion

First Submitted

First Posted

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (1)

Study Arms (1)

Vitrectomy

Interventions

Eligibility Criteria

You may qualify if:

You may not qualify if:

Sponsors & Collaborators

Study Sites (1)

Related Links

MeSH Terms

Interventions

Intervention Hierarchy (Ancestors)

Enrollment

Study Design

Study Record Dates

Source record

Locations

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

Primary Completion

Study Completion

First Submitted

First Posted

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (1)

Study Arms (1)

Vitrectomy

Interventions

Eligibility Criteria

You may qualify if:

You may not qualify if:

Sponsors & Collaborators

Study Sites (1)

Related Links

MeSH Terms

Interventions

Intervention Hierarchy (Ancestors)

Enrollment

Study Design

Study Record Dates

Source record

Locations